Close

Amgen (AMGN) PT Lowered to $288 at Cowen

February 3, 2021 6:21 AM EST
Get Alerts AMGN Hot Sheet
Price: $285.11 -0.42%

Rating Summary:
    20 Buy, 13 Hold, 5 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE

Cowen analyst Yaron Werber lowered the price target on Amgen (NASDAQ: AMGN) to $288.00 (from $294.00) while maintaining a Outperform rating.

The analyst commented, "Q4 EPS beat driven by other income as revs and OpEx were mainly in-line. Strength of Neulasta, Prolia, Repatha, Otezla and biosimilars drove modest rev upside. FY21 guidance reflects persistent COVID-19 headwinds and is largely in-line. We expect continued strong execution in Q1 despite seasonal weakness. We like risk/reward ahead of highly anticipated sotorasib combo data in H1:21 (likely ASCO)."



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change

Related Entities

Cowen & Co